Case report: anti-argonaute antibodies in Epstein-Barr virus encephalitis
- 6 September 2025
- journal article
- letter
- Published by Springer Nature in Journal of Neurology
- Vol. 272 (9) , 1-4
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Novel Perspectives Focused on the Relationship Between Herpesvirus Encephalitis and Anti-GFAP-Antibody-Positive AstrocytopathyMolecular Neurobiology, 2024
- Understanding the link between neurotropic viruses, BBB permeability, and MS pathogenesisJournal of NeuroVirology, 2024
- Early autoimmunity and outcome in virus encephalitis: a retrospective study based on tissue-based assayJournal of Neurology, Neurosurgery & Psychiatry, 2023
- Epstein–Barr virus encephalitis with excessive daytime sleepiness as the main manifestation: Two case reportsMedicine, 2022
- A Prospective Cohort Study to Identify Clinical, Biological, and Imaging Features That Predict the Etiology of Acute EncephalitisClinical Infectious Diseases, 2020
- Autoantibodies to Su/Argonaute 2 in Japanese patients with inflammatory myopathyClinica Chimica Acta, 2017
- CSF herpes virus and autoantibody profiles in the evaluation of encephalitisNeurology Neuroimmunology & Neuroinflammation, 2016
- Autoantibodies to Argonaute 2 (Su Antigen)2012
- N‐methyl‐D‐aspartate receptor antibodies in herpes simplex encephalitisAnnals of Neurology, 2012
- Characterization of a new antigen‐antibody system (su) in patients with systemic lupus erythematosusArthritis & Rheumatism, 1984